Abstract:Objective:To explore the changes in morphology and function of meibomian gland and the expressions of inflammatory factors and lipid metabolic factors in meibomian gland of diabetic mice.Methods:Fifty 8-week-old male C57BL/6 mice of clean degree were divided into normal control group ( n=20) and diabetes model group ( n=30) according to a random table.Diabetes model was established by the intraperitoneal injection of streptozotocin (60 mg/kg, 10 mg/ml). Mouse tail vein blood glucose ≥16.7 mmol/L was considered as successful modeling.Blood glucose was measured weekly, and body weight was compared between the two groups.Ten mice were randomly selected for fluorescein sodium staining of the cornea to evaluate the integrity of the corneal epithelium from both groups at an interval of 4 weeks.Five mice were randomly selected from the two groups and were sacrificed via anesthesia to collect meibomian gland tissue for hematoxylin and eosin staining in order to observe morphological changes at 8 and 16 weeks after modeling, respectively.At 16 weeks following modeling, mebomian gland of 5 mice randomly selected from both groups was stained with oil red O staining to observe the distribution of lipid.Real-time fluorescence quantitative-PCR was performed to detect the relative expressions of tumor necrosis factor (TNF)-α, pigment epithelium derived factor (PEDF), peroxisome proliferators-activated receptor γ (PPARγ), and adipose differentiation-related protein (ADFP) mRNA in meibomian gland.The use and care of animals complied with the ARVO statement.This study protocol was approved by the Institutional Animal Care and Use Committee of Tianjin Medical University Eye Hospital (No.TJYY20190630009). Results:The successful modeling rate of diabetes in mice was 100%, and the survival rate was 83.3% (25/30). The weight was significantly lower and the blood glucose level was higher in diabetes model group at 8 and 16 weeks after modeling in comparison with normal control group (all at P<0.05). There were significant differences in corneal fluorescein staining score among different time points in diabetes model group ( F=27.155, P<0.05). In diabetes model group, thinner wall of meibomian gland duct, enlarged lumen of the duct, dilated acini and oil red-stained lipid deposition in most acini were observed.At 16 weeks after modeling, the expressions of TNF-α, and PPARγ mRNA in meibomian gland of diabetes model group were 3.33±0.91 and 1.55±0.25, which were significantly higher than 1.00±0.16 and 1.00±0.27 of normal control group (both at P<0.05). The expression of PEDF mRNA in diabetes model group was 0.42±0.08, which was significantly lower than 1.00±0.34 in normal control group ( P<0.05). There was no significant difference in the ADFP mRNA expression between the two groups ( t=0.943, P=0.38). Conclusions:Inflammatory factors and lipid metabolic factors such as TNF-α, PEDF, and PPARγ may be involved in the pathogenesis of meibomian gland dysfunction induced by diabetes.

Role of inflammation in pathogenesis of meibomian gland dysfunction

Role of immune-mediated inflammation in the pathogenesis of dry eye

The treatment effectiveness of local application of glucocorticoid for meibomian gland dysfunction related dry eye

Malassezia Species May Play Potential Roles in the Pathogenesis of Meibomian Gland Dysfunction.

Therapeutic Effect of Intense Pulsed Light with Optimal Pulse Technology on Meibomian Gland Dysfunction with and Without Ocular Demodex Infestation

Analysis of Tear Inflammatory Molecules and Clinical Correlations in Evaporative Dry Eye Disease Caused by Meibomian Gland Dysfunction

Pathogens in the Meibomian Gland and Conjunctival Sac: Microbiome of Normal Subjects and Patients with Meibomian Gland Dysfunction.

Improving the understanding for meibomian gland dysfunction Paying attention to the management of meibomian gland dysfunction associated-dry eye

Meibomian Gland Dysfunction and Expressions of Inflammatory Factors and Lipid Metabolic Factors in Diabetic Mice

Inflammatory mechanisms in the pathologic lesions of dry eye

Rete Ridges in Eyelid Margin and Inflammatory Cytokines in Meibomian Gland Dysfunction Associated with Dry Eye Symptom

The inhibition of p38 MAPK blocked inflammation to restore the functions of rat meibomian gland epithelial cells

[Changes in human meibum with meibomian gland dysfunction].

Emerging treatment options for meibomian gland dysfunction.

The impact of keratoconjunctivitis associated with meibomian gland dysfunction

Preliminary investigation on the establishment of a new meibomian gland obstruction model and gene expression

Models for Meibomian Gland Dysfunction: in Vivo and in Vitro

Is Meibomian Gland Dysfunction One Disease? Heterogeneity Among Phenotypes

Melatonin Attenuates LPS-Induced Proinflammatory Cytokine Response and Lipogenesis in Human Meibomian Gland Epithelial Cells Via MAPK/NF-κB Pathway

Meibomian Gland Dysfunction: A Dermatological Perspective on Pathogenesis and Treatment Outlook

Emphasizing on the Role of Ocular Surface Inflammation in Dry Eye